Melatonin in rheumatoid arthritis
Phase 3
- Conditions
- Rheumatoid arthritis.Rheumatoid arthritis with rheumatoid factor
- Registration Number
- IRCT20191231045964N1
- Lead Sponsor
- Ahvaz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 70
Inclusion Criteria
They are eighteen to fifty years old
Patients are selected from both sexes
Patients with rheumatoid arthritis
Patients' body mass index is between 18/5_30
Exclusion Criteria
People taking antidepressants and sedatives
People who use alcohol and cigarettes
Taking antioxidant supplements within 3 months prior
People taking anticoagulants
Pregnant and lactating women
Any disease except rheumatoid arthritis
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Sleep quality. Timepoint: Before and after the intervention. Method of measurement: Questionnaire.;Intensity of pain. Timepoint: Before and after the intervention. Method of measurement: VAS Questionnaire.;Illness severity. Timepoint: Before and after the intervention. Method of measurement: DAS-28 Questionnaire.
- Secondary Outcome Measures
Name Time Method